GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (NAS:CDMOP.PFD) » Definitions » YoY EBITDA Growth

CDMOP.PFD (Avid Bioservices) YoY EBITDA Growth : 0.00% (As of Oct. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Avid Bioservices YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Avid Bioservices's YoY EBITDA Growth for the quarter that ended in Oct. 2024 was 0.00%.

Avid Bioservices's EBITDA per Share for the three months ended in Oct. 2024 was $0.00.


Avid Bioservices YoY EBITDA Growth Historical Data

The historical data trend for Avid Bioservices's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices YoY EBITDA Growth Chart

Avid Bioservices Annual Data
Trend Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Avid Bioservices Quarterly Data
Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Avid Bioservices YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Avid Bioservices's YoY EBITDA Growth for the fiscal year that ended in Apr. 2024 is calculated as:

YoY EBITDA Growth (A: Apr. 2024 )
=(EBITDA per Share (A: Apr. 2024 )-EBITDA per Share (A: Apr. 2023 ))/ | EBITDA per Share (A: Apr. 2023 ) |
=(-)/ | |
=N/A %

Avid Bioservices's YoY EBITDA Growth for the quarter that ended in Oct. 2024 is calculated as:

YoY EBITDA Growth (Q: Oct. 2024 )
=(EBITDA per Share (Q: Oct. 2024 )-EBITDA per Share (Q: Oct. 2023 )) / | EBITDA per Share (Q: Oct. 2023 )) |
=(-)/ | |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avid Bioservices YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Avid Bioservices Business Description

Traded in Other Exchanges
N/A
Address
14191 Myford Road, Tustin, CA, USA, 92780
Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.